Notable too: Funders include "the NIH/NCI (1R37CA279822-01) and the Yale Cancer Center (supported by NIH/NCI research grant P30CA016359). E.B. received support from the Dana-Farber Cancer Immunology Training Program (NIH T32CA207021)."
Notable too: Funders include "the NIH/NCI (1R37CA279822-01) and the Yale Cancer Center (supported by NIH/NCI research grant P30CA016359). E.B. received support from the Dana-Farber Cancer Immunology Training Program (NIH T32CA207021)."